News
3 Top Big Pharma Dividend Stocks You Can Buy Right Now
Big pharma stocks have long been favorites for dividend-seeking investors, and for good reason. Major pharmaceutical companies typically generate strong cash flow, which allows them to pay high....
What Investors Need to Know About Investing in Low PE Stocks
What do Warren Buffett, Ben Graham, Seth Klarman, and Peter Lynch all have in common? Besides being wildly successful investors, they're all are adherents to value investing, a method where one....
What Investors Need to Know About Investing in Low PE Stocks
What do Warren Buffett, Ben Graham, Seth Klarman, and Peter Lynch all have in common? Besides being wildly successful investors, they're all are adherents to value investing, a method where one....
What Investors Need to Know About Investing in Low PE Stocks
What do Warren Buffett, Ben Graham, Seth Klarman, and Peter Lynch all have in common? Besides being wildly successful investors, they're all are adherents to value investing, a method where one....
Why Roku, GGP, and Nektar Therapeutics Jumped Today
The stock market got off to a solid start on Monday, bouncing back from small losses early in the trading day to finish with modest gains. Major benchmarks were up less than a quarter percent as....
Why Sears Holdings, Immunomedics, and J.C. Penney Slumped Today
Monday was a good day for the stock market, with major benchmarks finishing with modest gains to sustain the generally bullish sentiment among investors. Some investors remain uncertain about....
Why Nektar Therapeutics Shares Are Rallying 13.8% Today
After the company presented results from an early-stage study of its NKTR-214 in solid tumor cancer at the 2017 Society for Immunotherapy of Cancer (SITC) annual meeting, Nektar Therapeutics....
Qiagen NV Meets Its Own 3rd-Quarter Expectations
Qiagen (NASDAQ: QGEN) reported third-quarter earnings in line with its revenue and earnings guidance, which disappointed investors who have come to expect earnings beats.MetricQ3 2017Continue....
Qiagen NV Meets Its Own 3rd-Quarter Expectations
Qiagen (NASDAQ: QGEN) reported third-quarter earnings in line with its revenue and earnings guidance, which disappointed investors who have come to expect earnings beats.MetricQ3 2017Continue....
Jounce Therapeutics, Inc. (JNCE) Q3 2017 Earnings Conference Call Transcript
Image source: The Motley Fool.Jounce Therapeutics, Inc. (NASDAQ: JNCE) Q3 2017 Earnings Conference CallNov. 13, 2017 8:00 a.m. ETOperatorContinue readingSource: Fool.com
A Rare Quarterly Appearance by bluebird bio Inc.'s Management
bluebird bio (NASDAQ: BLUE) released third-quarter earnings complete with a conference call, which the biotech doesn't usually hold for quarterly results, but this quarter was different with....
3 Top Healthcare Stocks to Buy in November
At 14.1%, healthcare is the third largest weighted sector in the S&P 500 index, and with 76 million baby boomers getting older and living longer, owning healthcare stocks in your portfolio....
Is Exact Sciences Corporation Stock a Buy?
Owning a stock that doubles in value in less than 11 months is exciting. But what word do you use for a stock that rises to 4.5 times its original price in that amount of time? Thrilling?....
Evotec: Nur eine Korrektur oder droht Schlimmeres?
Irgendwann trifft es auch die beste Aktie. In der letzten Handelswoche war nun Evotec an der Reihe. Nach einer monatelangen Rally ab Februar 2016 im Zuge derer der Kurs Bitcoin-artig um fast 700 %....
So, This Is What the End of Obamacare Looks Like
For better or worse, the Affordable Care Act (ACA) has been the law of the land since it was signed into law in March 2010 and officially was enacted in the individual insurance markets in 2014.In....
So, This Is What the End of Obamacare Looks Like
For better or worse, the Affordable Care Act (ACA) has been the law of the land since it was signed into law in March 2010 and officially was enacted in the individual insurance markets in 2014.In....
5 Irresistible Reasons to Buy Celgene Stock Right Now (Hint: 1 Is that It's Dirt Cheap)
If you're looking for a smart stock to buy right now, look no further than Celgene (NASDAQ: CELG). The big biotech has hit a rough patch lately, with a major clinical setback, missing....
Better Buy: Exelixis, Inc. vs. Novartis AG
Novartis (NYSE: NVS) stands out as one of the biggest pharma companies with a broad array of products, including several of the most powerful cancer drugs on the market. Exelixis (NASDAQ: EXEL)....
3 Top Biotech Stocks for 2018
Biotech stocks have been outstanding growth vehicles over the past six-plus years. The industry is still in "hypergrowth" mode because of a number of favorable tailwinds, such as an aging global....
3 Biotech Stocks That Soared This Week: Are They Buys?
Earnings season continued to be in high gear this week. Positive quarterly results helped propel several biotech stocks higher over the last few days. Others jumped because of good news for their....
3 Growth Stocks for Farsighted Investors
Investing in so-called growth stocks can be as exciting as it is frustrating. All too often, investors who own growth stocks panic when they realize that the road to market-beating gains is....
3 Growth Stocks for Farsighted Investors
Investing in so-called growth stocks can be as exciting as it is frustrating. All too often, investors who own growth stocks panic when they realize that the road to market-beating gains is....
3 Growth Stocks for Farsighted Investors
Investing in so-called growth stocks can be as exciting as it is frustrating. All too often, investors who own growth stocks panic when they realize that the road to market-beating gains is....
Obamacare Was Destined to Fail, Even Without Trump
In case you missed it, open enrollment for the Affordable Care Act's (ACA) fifth year is underway, through Dec. 15, 2017, or perhaps a bit longer in select states. The upcoming year of enrollment....
Obamacare Was Destined to Fail, Even Without Trump
In case you missed it, open enrollment for the Affordable Care Act's (ACA) fifth year is underway, through Dec. 15, 2017, or perhaps a bit longer in select states. The upcoming year of enrollment....